Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?

03 Aug 2012 Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?

In an article published in the BMJ on July 18 Andrew Jack, pharmaceuticals correspondent, Financial Times asks if the heyday of such aggressive marketing of pharmaceuticals (as the one that led to Glaxo being fined $3bn last month) may be a thing of the past. Read the article here: http://www.bmj.com/content/345/bmj.e4865 

A rapid response by La Revue Prescrire highlights the need to say “no thanks” to the pharmaceutical industry’s undue influence: http://www.bmj.com/content/345/bmj.e4865?tab=responses